SLOWDOWN FOR SWITCHES

Recent controversies over prescription medicines may result in a slower pace in switching drugs to over-the-counter status, supermarket pharmacy executives told SN.Because of the increased scrutiny given drugs in the COX-2 class of nonsteroidal anti-inflammatory drugs, such as Vioxx, Celebrex and Bextra, the U.S. Food and Drug Administration is likely to be more careful in approving OTC switches.

Recent controversies over prescription medicines may result in a slower pace in switching drugs to over-the-counter status, supermarket pharmacy executives told SN.

Because of the increased scrutiny given drugs in the COX-2 class of nonsteroidal anti-inflammatory drugs, such as Vioxx, Celebrex and Bextra, the U.S. Food and Drug Administration is likely to be more careful in approving OTC switches. For example, the anti-cholesterol drugs known as statins, although long mentioned as can

Register to view the full article

test - Advanced Registered User

Already a member? .